Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
Letter to the Editor: Reconsidering relevance of endoscopic ultrasound-guided radiofrequency ablation in pancreatic cancer treatment: Future perspectives on artificial intelligence
Avinash D Gautam, Hira Lal, Department of Radiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226014, Uttar Pradesh, India
Author contributions: Gautam AD and Lal H contributed to the conception and design of the manuscript, literature review, data interpretation, and critical revision of the manuscript; Gautam AD and Lal H approved the final version of the manuscript and agree to be accountable for all aspects of the work.
AI contribution statement: The authors take full responsibility and accountability for all content of this manuscript, including any portions for which AI tools were used as assistive technologies. All AI-assisted outputs were carefully reviewed, validated, and approved by the authors. AI tools were not used to generate original scientific data, perform independent scientific analyses, or draw scientific conclusions.
Conflict-of-interest statement: All authors declare that they have no conflict of interest to disclose.
Corresponding author: Hira Lal, Professor, Department of Radiology, Sanjay Gandhi Post graduate Institute of Medical Sciences, Raibareli Road, Lucknow 226014, Uttar Pradesh, India. hiralal2007@yahoo.co.in
Received: June 9, 2026
Revised: August 13, 2026
Accepted: August 21, 2026
Published online: September 28, 2026
Processing time: 111 Days and 4.4 Hours
Revised: August 13, 2026
Accepted: August 21, 2026
Published online: September 28, 2026
Processing time: 111 Days and 4.4 Hours
Core Tip
Core Tip: Pancreatic cancer is a serious clinical challenge associated with high morbidity and mortality. Treatment options for non-resectable or high-risk patients are limited. Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) is an emerging therapeutic approach, albeit with certain limitations. Tong et al highlighted the role of EUS-RFA in pancreatic cancer treatment in their recent review.